Document is current
Any future updates will be listed below
-
Authors
Adegbola, Samuel O. https://orcid.org/0000-0003-2522-3895
Dibley, Lesley
Sahnan, Kapil
Wade, Tiffany
Verjee, Azmina
Sawyer, Rachel
Mannick, Sameer
McCluskey, Damian
Yassin, Nuha
Phillips, Robin K. S.
Tozer, Philip J.
Norton, Christine
Hart, Ailsa L.
-
Funding
Funding for this research was provided by:
Bowel Disease Research Foundation
- License Information
-
More Information
Article History
Received: 28 May 2020
Accepted: 6 November 2020
First Online: 20 November 2020
Competing interests
: KS, PJT and SOA have received honoraria from Takeda for sitting on an advisory board. PJT has received honoraria from Takeda for speaking at a symposium. Lesley Dibley: speaker’s fees from Janssen and AbbVie; consultancy fees from GL Assessments. Christine Norton: speaker’s fees from Takeda, Tillots Pharma and Ferring Pharmaceuticals. ALH has served as a consultant, advisory board member or speaker for AbbVie, atlantic, Bristol-Myers Squibb, Celltrion, Falk, Ferring, Janssen, MSD, Napp Pharmaceuticals, Pfizer, Pharmacosmos, Shire and Takeda. She also serves on the global Steering committee for Genentech.
